Post-Exposure Vaccination Improves Gammaherpesvirus Neutralization
Herpesvirus carriers transmit infection despite making virus-specific antibodies. Thus, their antibody responses are not necessarily optimal. An important question for infection control is whether vaccinating carriers might improve virus neutralization. The antibody response to murine gamma-herpesvi...
Main Authors: | , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2007
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1964807/ |
id |
pubmed-1964807 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-19648072007-09-19 Post-Exposure Vaccination Improves Gammaherpesvirus Neutralization Gillet, Laurent May, Janet S. Stevenson, Philip G. Research Article Herpesvirus carriers transmit infection despite making virus-specific antibodies. Thus, their antibody responses are not necessarily optimal. An important question for infection control is whether vaccinating carriers might improve virus neutralization. The antibody response to murine gamma-herpesvirus-68 (MHV-68) blocks cell binding, but fails to block and even enhances an IgG Fc receptor-dependent infection of myeloid cells. Viral membrane fusion therefore remains intact. Although gH/gL-specific monoclonal antibodies can block infection at a post-binding step close to membrane fusion, gH/gL is a relatively minor antibody target in virus carriers. We show here that gH/gL-specific antibodies can block both Fc receptor-independent and Fc receptor-dependent infections, and that vaccinating virus carriers with a gH/gL fusion protein improves their capacity for virus neutralization both in vitro and in vivo. This approach has the potential to reduce herpesvirus transmission. Public Library of Science 2007-09-19 /pmc/articles/PMC1964807/ /pubmed/17878934 http://dx.doi.org/10.1371/journal.pone.0000899 Text en Gillet et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Gillet, Laurent May, Janet S. Stevenson, Philip G. |
spellingShingle |
Gillet, Laurent May, Janet S. Stevenson, Philip G. Post-Exposure Vaccination Improves Gammaherpesvirus Neutralization |
author_facet |
Gillet, Laurent May, Janet S. Stevenson, Philip G. |
author_sort |
Gillet, Laurent |
title |
Post-Exposure Vaccination Improves Gammaherpesvirus Neutralization |
title_short |
Post-Exposure Vaccination Improves Gammaherpesvirus Neutralization |
title_full |
Post-Exposure Vaccination Improves Gammaherpesvirus Neutralization |
title_fullStr |
Post-Exposure Vaccination Improves Gammaherpesvirus Neutralization |
title_full_unstemmed |
Post-Exposure Vaccination Improves Gammaherpesvirus Neutralization |
title_sort |
post-exposure vaccination improves gammaherpesvirus neutralization |
description |
Herpesvirus carriers transmit infection despite making virus-specific antibodies. Thus, their antibody responses are not necessarily optimal. An important question for infection control is whether vaccinating carriers might improve virus neutralization. The antibody response to murine gamma-herpesvirus-68 (MHV-68) blocks cell binding, but fails to block and even enhances an IgG Fc receptor-dependent infection of myeloid cells. Viral membrane fusion therefore remains intact. Although gH/gL-specific monoclonal antibodies can block infection at a post-binding step close to membrane fusion, gH/gL is a relatively minor antibody target in virus carriers. We show here that gH/gL-specific antibodies can block both Fc receptor-independent and Fc receptor-dependent infections, and that vaccinating virus carriers with a gH/gL fusion protein improves their capacity for virus neutralization both in vitro and in vivo. This approach has the potential to reduce herpesvirus transmission. |
publisher |
Public Library of Science |
publishDate |
2007 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1964807/ |
_version_ |
1611399461645320192 |